Phoenix Pharma’s Acquisition of OCP Répartition
On September 30th, 2022, the French Competition Authority (ADLC) cleared the acquisition of OCP Repartition, subsidiary of McKesson Europe, by Phoenix Group with minor behavioural remedies following Phase I review.